Global Opioids Agonist Drugs Market Research Report 2023(Status and Outlook)
Report Overview
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
Bosson Research’s latest report provides a deep insight into the global Opioids Agonist Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioids Agonist Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioids Agonist Drugs market in any manner.
Global Opioids Agonist Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Market Segmentation (by Type)
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Market Segmentation (by Application)
Pain Management
Cough Treatment
Diarrhea Treatment
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Opioids Agonist Drugs Market
Overview of the regional outlook of the Opioids Agonist Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioids Agonist Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
Bosson Research’s latest report provides a deep insight into the global Opioids Agonist Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioids Agonist Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioids Agonist Drugs market in any manner.
Global Opioids Agonist Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Market Segmentation (by Type)
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Market Segmentation (by Application)
Pain Management
Cough Treatment
Diarrhea Treatment
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Opioids Agonist Drugs Market
Overview of the regional outlook of the Opioids Agonist Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioids Agonist Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Opioids Agonist Drugs
1.2 Key Market Segments
1.2.1 Opioids Agonist Drugs Segment by Type
1.2.2 Opioids Agonist Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPIOIDS AGONIST DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Opioids Agonist Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Opioids Agonist Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPIOIDS AGONIST DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Opioids Agonist Drugs Sales by Manufacturers (2018-2023)
3.2 Global Opioids Agonist Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioids Agonist Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Opioids Agonist Drugs Sales Sites, Area Served, Product Type
3.6 Opioids Agonist Drugs Market Competitive Situation and Trends
3.6.1 Opioids Agonist Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioids Agonist Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OPIOIDS AGONIST DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Opioids Agonist Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPIOIDS AGONIST DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OPIOIDS AGONIST DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
6.3 Global Opioids Agonist Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Opioids Agonist Drugs Price by Type (2018-2023)
7 OPIOIDS AGONIST DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioids Agonist Drugs Market Sales by Application (2018-2023)
7.3 Global Opioids Agonist Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Opioids Agonist Drugs Sales Growth Rate by Application (2018-2023)
8 OPIOIDS AGONIST DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Opioids Agonist Drugs Sales by Region
8.1.1 Global Opioids Agonist Drugs Sales by Region
8.1.2 Global Opioids Agonist Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Opioids Agonist Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioids Agonist Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioids Agonist Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioids Agonist Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioids Agonist Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Purdue Pharma
9.1.1 Purdue Pharma Opioids Agonist Drugs Basic Information
9.1.2 Purdue Pharma Opioids Agonist Drugs Product Overview
9.1.3 Purdue Pharma Opioids Agonist Drugs Product Market Performance
9.1.4 Purdue Pharma Business Overview
9.1.5 Purdue Pharma Opioids Agonist Drugs SWOT Analysis
9.1.6 Purdue Pharma Recent Developments
9.2 Titan pharmaceuticals
9.2.1 Titan pharmaceuticals Opioids Agonist Drugs Basic Information
9.2.2 Titan pharmaceuticals Opioids Agonist Drugs Product Overview
9.2.3 Titan pharmaceuticals Opioids Agonist Drugs Product Market Performance
9.2.4 Titan pharmaceuticals Business Overview
9.2.5 Titan pharmaceuticals Opioids Agonist Drugs SWOT Analysis
9.2.6 Titan pharmaceuticals Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Opioids Agonist Drugs Basic Information
9.3.2 Boehringer Ingelheim Opioids Agonist Drugs Product Overview
9.3.3 Boehringer Ingelheim Opioids Agonist Drugs Product Market Performance
9.3.4 Boehringer Ingelheim Business Overview
9.3.5 Boehringer Ingelheim Opioids Agonist Drugs SWOT Analysis
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Janssen Pharmaceuticals, Inc
9.4.1 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Basic Information
9.4.2 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Overview
9.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Market Performance
9.4.4 Janssen Pharmaceuticals, Inc Business Overview
9.4.5 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs SWOT Analysis
9.4.6 Janssen Pharmaceuticals, Inc Recent Developments
9.5 Sanofi
9.5.1 Sanofi Opioids Agonist Drugs Basic Information
9.5.2 Sanofi Opioids Agonist Drugs Product Overview
9.5.3 Sanofi Opioids Agonist Drugs Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Opioids Agonist Drugs SWOT Analysis
9.5.6 Sanofi Recent Developments
9.6 Sun Pharmaceuticals
9.6.1 Sun Pharmaceuticals Opioids Agonist Drugs Basic Information
9.6.2 Sun Pharmaceuticals Opioids Agonist Drugs Product Overview
9.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Product Market Performance
9.6.4 Sun Pharmaceuticals Business Overview
9.6.5 Sun Pharmaceuticals Recent Developments
9.7 Mallinckrodt Pharmaceuticals
9.7.1 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Basic Information
9.7.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Overview
9.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Market Performance
9.7.4 Mallinckrodt Pharmaceuticals Business Overview
9.7.5 Mallinckrodt Pharmaceuticals Recent Developments
9.8 Egalet Corporation
9.8.1 Egalet Corporation Opioids Agonist Drugs Basic Information
9.8.2 Egalet Corporation Opioids Agonist Drugs Product Overview
9.8.3 Egalet Corporation Opioids Agonist Drugs Product Market Performance
9.8.4 Egalet Corporation Business Overview
9.8.5 Egalet Corporation Recent Developments
9.9 Endo Pharmaceuticals Inc.
9.9.1 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Basic Information
9.9.2 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Overview
9.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Market Performance
9.9.4 Endo Pharmaceuticals Inc. Business Overview
9.9.5 Endo Pharmaceuticals Inc. Recent Developments
9.10 Allergan, Plc
9.10.1 Allergan, Plc Opioids Agonist Drugs Basic Information
9.10.2 Allergan, Plc Opioids Agonist Drugs Product Overview
9.10.3 Allergan, Plc Opioids Agonist Drugs Product Market Performance
9.10.4 Allergan, Plc Business Overview
9.10.5 Allergan, Plc Recent Developments
9.11 Pfizer Inc
9.11.1 Pfizer Inc Opioids Agonist Drugs Basic Information
9.11.2 Pfizer Inc Opioids Agonist Drugs Product Overview
9.11.3 Pfizer Inc Opioids Agonist Drugs Product Market Performance
9.11.4 Pfizer Inc Business Overview
9.11.5 Pfizer Inc Recent Developments
10 OPIOIDS AGONIST DRUGS MARKET FORECAST BY REGION
10.1 Global Opioids Agonist Drugs Market Size Forecast
10.2 Global Opioids Agonist Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioids Agonist Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Opioids Agonist Drugs Market Size Forecast by Region
10.2.4 South America Opioids Agonist Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioids Agonist Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Opioids Agonist Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Opioids Agonist Drugs by Type (2024-2029)
11.1.2 Global Opioids Agonist Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Opioids Agonist Drugs by Type (2024-2029)
11.2 Global Opioids Agonist Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Opioids Agonist Drugs Sales (K MT) Forecast by Application
11.2.2 Global Opioids Agonist Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Opioids Agonist Drugs
1.2 Key Market Segments
1.2.1 Opioids Agonist Drugs Segment by Type
1.2.2 Opioids Agonist Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPIOIDS AGONIST DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Opioids Agonist Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Opioids Agonist Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPIOIDS AGONIST DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Opioids Agonist Drugs Sales by Manufacturers (2018-2023)
3.2 Global Opioids Agonist Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioids Agonist Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Opioids Agonist Drugs Sales Sites, Area Served, Product Type
3.6 Opioids Agonist Drugs Market Competitive Situation and Trends
3.6.1 Opioids Agonist Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioids Agonist Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OPIOIDS AGONIST DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Opioids Agonist Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPIOIDS AGONIST DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OPIOIDS AGONIST DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
6.3 Global Opioids Agonist Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Opioids Agonist Drugs Price by Type (2018-2023)
7 OPIOIDS AGONIST DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioids Agonist Drugs Market Sales by Application (2018-2023)
7.3 Global Opioids Agonist Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Opioids Agonist Drugs Sales Growth Rate by Application (2018-2023)
8 OPIOIDS AGONIST DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Opioids Agonist Drugs Sales by Region
8.1.1 Global Opioids Agonist Drugs Sales by Region
8.1.2 Global Opioids Agonist Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Opioids Agonist Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioids Agonist Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioids Agonist Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioids Agonist Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioids Agonist Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Purdue Pharma
9.1.1 Purdue Pharma Opioids Agonist Drugs Basic Information
9.1.2 Purdue Pharma Opioids Agonist Drugs Product Overview
9.1.3 Purdue Pharma Opioids Agonist Drugs Product Market Performance
9.1.4 Purdue Pharma Business Overview
9.1.5 Purdue Pharma Opioids Agonist Drugs SWOT Analysis
9.1.6 Purdue Pharma Recent Developments
9.2 Titan pharmaceuticals
9.2.1 Titan pharmaceuticals Opioids Agonist Drugs Basic Information
9.2.2 Titan pharmaceuticals Opioids Agonist Drugs Product Overview
9.2.3 Titan pharmaceuticals Opioids Agonist Drugs Product Market Performance
9.2.4 Titan pharmaceuticals Business Overview
9.2.5 Titan pharmaceuticals Opioids Agonist Drugs SWOT Analysis
9.2.6 Titan pharmaceuticals Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Opioids Agonist Drugs Basic Information
9.3.2 Boehringer Ingelheim Opioids Agonist Drugs Product Overview
9.3.3 Boehringer Ingelheim Opioids Agonist Drugs Product Market Performance
9.3.4 Boehringer Ingelheim Business Overview
9.3.5 Boehringer Ingelheim Opioids Agonist Drugs SWOT Analysis
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Janssen Pharmaceuticals, Inc
9.4.1 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Basic Information
9.4.2 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Overview
9.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Market Performance
9.4.4 Janssen Pharmaceuticals, Inc Business Overview
9.4.5 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs SWOT Analysis
9.4.6 Janssen Pharmaceuticals, Inc Recent Developments
9.5 Sanofi
9.5.1 Sanofi Opioids Agonist Drugs Basic Information
9.5.2 Sanofi Opioids Agonist Drugs Product Overview
9.5.3 Sanofi Opioids Agonist Drugs Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Opioids Agonist Drugs SWOT Analysis
9.5.6 Sanofi Recent Developments
9.6 Sun Pharmaceuticals
9.6.1 Sun Pharmaceuticals Opioids Agonist Drugs Basic Information
9.6.2 Sun Pharmaceuticals Opioids Agonist Drugs Product Overview
9.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Product Market Performance
9.6.4 Sun Pharmaceuticals Business Overview
9.6.5 Sun Pharmaceuticals Recent Developments
9.7 Mallinckrodt Pharmaceuticals
9.7.1 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Basic Information
9.7.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Overview
9.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Market Performance
9.7.4 Mallinckrodt Pharmaceuticals Business Overview
9.7.5 Mallinckrodt Pharmaceuticals Recent Developments
9.8 Egalet Corporation
9.8.1 Egalet Corporation Opioids Agonist Drugs Basic Information
9.8.2 Egalet Corporation Opioids Agonist Drugs Product Overview
9.8.3 Egalet Corporation Opioids Agonist Drugs Product Market Performance
9.8.4 Egalet Corporation Business Overview
9.8.5 Egalet Corporation Recent Developments
9.9 Endo Pharmaceuticals Inc.
9.9.1 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Basic Information
9.9.2 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Overview
9.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Market Performance
9.9.4 Endo Pharmaceuticals Inc. Business Overview
9.9.5 Endo Pharmaceuticals Inc. Recent Developments
9.10 Allergan, Plc
9.10.1 Allergan, Plc Opioids Agonist Drugs Basic Information
9.10.2 Allergan, Plc Opioids Agonist Drugs Product Overview
9.10.3 Allergan, Plc Opioids Agonist Drugs Product Market Performance
9.10.4 Allergan, Plc Business Overview
9.10.5 Allergan, Plc Recent Developments
9.11 Pfizer Inc
9.11.1 Pfizer Inc Opioids Agonist Drugs Basic Information
9.11.2 Pfizer Inc Opioids Agonist Drugs Product Overview
9.11.3 Pfizer Inc Opioids Agonist Drugs Product Market Performance
9.11.4 Pfizer Inc Business Overview
9.11.5 Pfizer Inc Recent Developments
10 OPIOIDS AGONIST DRUGS MARKET FORECAST BY REGION
10.1 Global Opioids Agonist Drugs Market Size Forecast
10.2 Global Opioids Agonist Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioids Agonist Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Opioids Agonist Drugs Market Size Forecast by Region
10.2.4 South America Opioids Agonist Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioids Agonist Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Opioids Agonist Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Opioids Agonist Drugs by Type (2024-2029)
11.1.2 Global Opioids Agonist Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Opioids Agonist Drugs by Type (2024-2029)
11.2 Global Opioids Agonist Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Opioids Agonist Drugs Sales (K MT) Forecast by Application
11.2.2 Global Opioids Agonist Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioids Agonist Drugs Market Size Comparison by Region (M USD)
Table 5. Global Opioids Agonist Drugs Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Opioids Agonist Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Opioids Agonist Drugs Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Opioids Agonist Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2022)
Table 10. Global Market Opioids Agonist Drugs Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Opioids Agonist Drugs Sales Sites and Area Served
Table 12. Manufacturers Opioids Agonist Drugs Product Type
Table 13. Global Opioids Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioids Agonist Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioids Agonist Drugs Market Challenges
Table 22. Market Restraints
Table 23. Global Opioids Agonist Drugs Sales by Type (K MT)
Table 24. Global Opioids Agonist Drugs Market Size by Type (M USD)
Table 25. Global Opioids Agonist Drugs Sales (K MT) by Type (2018-2023)
Table 26. Global Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Table 27. Global Opioids Agonist Drugs Market Size (M USD) by Type (2018-2023)
Table 28. Global Opioids Agonist Drugs Market Size Share by Type (2018-2023)
Table 29. Global Opioids Agonist Drugs Price (USD/MT) by Type (2018-2023)
Table 30. Global Opioids Agonist Drugs Sales (K MT) by Application
Table 31. Global Opioids Agonist Drugs Market Size by Application
Table 32. Global Opioids Agonist Drugs Sales by Application (2018-2023) & (K MT)
Table 33. Global Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Table 34. Global Opioids Agonist Drugs Sales by Application (2018-2023) & (M USD)
Table 35. Global Opioids Agonist Drugs Market Share by Application (2018-2023)
Table 36. Global Opioids Agonist Drugs Sales Growth Rate by Application (2018-2023)
Table 37. Global Opioids Agonist Drugs Sales by Region (2018-2023) & (K MT)
Table 38. Global Opioids Agonist Drugs Sales Market Share by Region (2018-2023)
Table 39. North America Opioids Agonist Drugs Sales by Country (2018-2023) & (K MT)
Table 40. Europe Opioids Agonist Drugs Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Opioids Agonist Drugs Sales by Region (2018-2023) & (K MT)
Table 42. South America Opioids Agonist Drugs Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Opioids Agonist Drugs Sales by Region (2018-2023) & (K MT)
Table 44. Purdue Pharma Opioids Agonist Drugs Basic Information
Table 45. Purdue Pharma Opioids Agonist Drugs Product Overview
Table 46. Purdue Pharma Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Purdue Pharma Business Overview
Table 48. Purdue Pharma Opioids Agonist Drugs SWOT Analysis
Table 49. Purdue Pharma Recent Developments
Table 50. Titan pharmaceuticals Opioids Agonist Drugs Basic Information
Table 51. Titan pharmaceuticals Opioids Agonist Drugs Product Overview
Table 52. Titan pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Titan pharmaceuticals Business Overview
Table 54. Titan pharmaceuticals Opioids Agonist Drugs SWOT Analysis
Table 55. Titan pharmaceuticals Recent Developments
Table 56. Boehringer Ingelheim Opioids Agonist Drugs Basic Information
Table 57. Boehringer Ingelheim Opioids Agonist Drugs Product Overview
Table 58. Boehringer Ingelheim Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Opioids Agonist Drugs SWOT Analysis
Table 61. Boehringer Ingelheim Recent Developments
Table 62. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Basic Information
Table 63. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Overview
Table 64. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Janssen Pharmaceuticals, Inc Business Overview
Table 66. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs SWOT Analysis
Table 67. Janssen Pharmaceuticals, Inc Recent Developments
Table 68. Sanofi Opioids Agonist Drugs Basic Information
Table 69. Sanofi Opioids Agonist Drugs Product Overview
Table 70. Sanofi Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Sanofi Business Overview
Table 72. Sanofi Opioids Agonist Drugs SWOT Analysis
Table 73. Sanofi Recent Developments
Table 74. Sun Pharmaceuticals Opioids Agonist Drugs Basic Information
Table 75. Sun Pharmaceuticals Opioids Agonist Drugs Product Overview
Table 76. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Sun Pharmaceuticals Business Overview
Table 78. Sun Pharmaceuticals Recent Developments
Table 79. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Basic Information
Table 80. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Overview
Table 81. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Mallinckrodt Pharmaceuticals Business Overview
Table 83. Mallinckrodt Pharmaceuticals Recent Developments
Table 84. Egalet Corporation Opioids Agonist Drugs Basic Information
Table 85. Egalet Corporation Opioids Agonist Drugs Product Overview
Table 86. Egalet Corporation Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Egalet Corporation Business Overview
Table 88. Egalet Corporation Recent Developments
Table 89. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Basic Information
Table 90. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Overview
Table 91. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Endo Pharmaceuticals Inc. Business Overview
Table 93. Endo Pharmaceuticals Inc. Recent Developments
Table 94. Allergan, Plc Opioids Agonist Drugs Basic Information
Table 95. Allergan, Plc Opioids Agonist Drugs Product Overview
Table 96. Allergan, Plc Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Allergan, Plc Business Overview
Table 98. Allergan, Plc Recent Developments
Table 99. Pfizer Inc Opioids Agonist Drugs Basic Information
Table 100. Pfizer Inc Opioids Agonist Drugs Product Overview
Table 101. Pfizer Inc Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Pfizer Inc Business Overview
Table 103. Pfizer Inc Recent Developments
Table 104. Global Opioids Agonist Drugs Sales Forecast by Region (2024-2029) & (K MT)
Table 105. Global Opioids Agonist Drugs Market Size Forecast by Region (2024-2029) & (M USD)
Table 106. North America Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 107. North America Opioids Agonist Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 108. Europe Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 109. Europe Opioids Agonist Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 110. Asia Pacific Opioids Agonist Drugs Sales Forecast by Region (2024-2029) & (K MT)
Table 111. Asia Pacific Opioids Agonist Drugs Market Size Forecast by Region (2024-2029) & (M USD)
Table 112. South America Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 113. South America Opioids Agonist Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 114. Middle East and Africa Opioids Agonist Drugs Consumption Forecast by Country (2024-2029) & (Units)
Table 115. Middle East and Africa Opioids Agonist Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 116. Global Opioids Agonist Drugs Sales Forecast by Type (2024-2029) & (K MT)
Table 117. Global Opioids Agonist Drugs Market Size Forecast by Type (2024-2029) & (M USD)
Table 118. Global Opioids Agonist Drugs Price Forecast by Type (2024-2029) & (USD/MT)
Table 119. Global Opioids Agonist Drugs Sales (K MT) Forecast by Application (2024-2029)
Table 120. Global Opioids Agonist Drugs Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioids Agonist Drugs Market Size Comparison by Region (M USD)
Table 5. Global Opioids Agonist Drugs Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Opioids Agonist Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Opioids Agonist Drugs Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Opioids Agonist Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2022)
Table 10. Global Market Opioids Agonist Drugs Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Opioids Agonist Drugs Sales Sites and Area Served
Table 12. Manufacturers Opioids Agonist Drugs Product Type
Table 13. Global Opioids Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioids Agonist Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioids Agonist Drugs Market Challenges
Table 22. Market Restraints
Table 23. Global Opioids Agonist Drugs Sales by Type (K MT)
Table 24. Global Opioids Agonist Drugs Market Size by Type (M USD)
Table 25. Global Opioids Agonist Drugs Sales (K MT) by Type (2018-2023)
Table 26. Global Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Table 27. Global Opioids Agonist Drugs Market Size (M USD) by Type (2018-2023)
Table 28. Global Opioids Agonist Drugs Market Size Share by Type (2018-2023)
Table 29. Global Opioids Agonist Drugs Price (USD/MT) by Type (2018-2023)
Table 30. Global Opioids Agonist Drugs Sales (K MT) by Application
Table 31. Global Opioids Agonist Drugs Market Size by Application
Table 32. Global Opioids Agonist Drugs Sales by Application (2018-2023) & (K MT)
Table 33. Global Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Table 34. Global Opioids Agonist Drugs Sales by Application (2018-2023) & (M USD)
Table 35. Global Opioids Agonist Drugs Market Share by Application (2018-2023)
Table 36. Global Opioids Agonist Drugs Sales Growth Rate by Application (2018-2023)
Table 37. Global Opioids Agonist Drugs Sales by Region (2018-2023) & (K MT)
Table 38. Global Opioids Agonist Drugs Sales Market Share by Region (2018-2023)
Table 39. North America Opioids Agonist Drugs Sales by Country (2018-2023) & (K MT)
Table 40. Europe Opioids Agonist Drugs Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Opioids Agonist Drugs Sales by Region (2018-2023) & (K MT)
Table 42. South America Opioids Agonist Drugs Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Opioids Agonist Drugs Sales by Region (2018-2023) & (K MT)
Table 44. Purdue Pharma Opioids Agonist Drugs Basic Information
Table 45. Purdue Pharma Opioids Agonist Drugs Product Overview
Table 46. Purdue Pharma Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Purdue Pharma Business Overview
Table 48. Purdue Pharma Opioids Agonist Drugs SWOT Analysis
Table 49. Purdue Pharma Recent Developments
Table 50. Titan pharmaceuticals Opioids Agonist Drugs Basic Information
Table 51. Titan pharmaceuticals Opioids Agonist Drugs Product Overview
Table 52. Titan pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Titan pharmaceuticals Business Overview
Table 54. Titan pharmaceuticals Opioids Agonist Drugs SWOT Analysis
Table 55. Titan pharmaceuticals Recent Developments
Table 56. Boehringer Ingelheim Opioids Agonist Drugs Basic Information
Table 57. Boehringer Ingelheim Opioids Agonist Drugs Product Overview
Table 58. Boehringer Ingelheim Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Opioids Agonist Drugs SWOT Analysis
Table 61. Boehringer Ingelheim Recent Developments
Table 62. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Basic Information
Table 63. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Overview
Table 64. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Janssen Pharmaceuticals, Inc Business Overview
Table 66. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs SWOT Analysis
Table 67. Janssen Pharmaceuticals, Inc Recent Developments
Table 68. Sanofi Opioids Agonist Drugs Basic Information
Table 69. Sanofi Opioids Agonist Drugs Product Overview
Table 70. Sanofi Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Sanofi Business Overview
Table 72. Sanofi Opioids Agonist Drugs SWOT Analysis
Table 73. Sanofi Recent Developments
Table 74. Sun Pharmaceuticals Opioids Agonist Drugs Basic Information
Table 75. Sun Pharmaceuticals Opioids Agonist Drugs Product Overview
Table 76. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Sun Pharmaceuticals Business Overview
Table 78. Sun Pharmaceuticals Recent Developments
Table 79. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Basic Information
Table 80. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Overview
Table 81. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Mallinckrodt Pharmaceuticals Business Overview
Table 83. Mallinckrodt Pharmaceuticals Recent Developments
Table 84. Egalet Corporation Opioids Agonist Drugs Basic Information
Table 85. Egalet Corporation Opioids Agonist Drugs Product Overview
Table 86. Egalet Corporation Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Egalet Corporation Business Overview
Table 88. Egalet Corporation Recent Developments
Table 89. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Basic Information
Table 90. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Overview
Table 91. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Endo Pharmaceuticals Inc. Business Overview
Table 93. Endo Pharmaceuticals Inc. Recent Developments
Table 94. Allergan, Plc Opioids Agonist Drugs Basic Information
Table 95. Allergan, Plc Opioids Agonist Drugs Product Overview
Table 96. Allergan, Plc Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Allergan, Plc Business Overview
Table 98. Allergan, Plc Recent Developments
Table 99. Pfizer Inc Opioids Agonist Drugs Basic Information
Table 100. Pfizer Inc Opioids Agonist Drugs Product Overview
Table 101. Pfizer Inc Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Pfizer Inc Business Overview
Table 103. Pfizer Inc Recent Developments
Table 104. Global Opioids Agonist Drugs Sales Forecast by Region (2024-2029) & (K MT)
Table 105. Global Opioids Agonist Drugs Market Size Forecast by Region (2024-2029) & (M USD)
Table 106. North America Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 107. North America Opioids Agonist Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 108. Europe Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 109. Europe Opioids Agonist Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 110. Asia Pacific Opioids Agonist Drugs Sales Forecast by Region (2024-2029) & (K MT)
Table 111. Asia Pacific Opioids Agonist Drugs Market Size Forecast by Region (2024-2029) & (M USD)
Table 112. South America Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 113. South America Opioids Agonist Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 114. Middle East and Africa Opioids Agonist Drugs Consumption Forecast by Country (2024-2029) & (Units)
Table 115. Middle East and Africa Opioids Agonist Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 116. Global Opioids Agonist Drugs Sales Forecast by Type (2024-2029) & (K MT)
Table 117. Global Opioids Agonist Drugs Market Size Forecast by Type (2024-2029) & (M USD)
Table 118. Global Opioids Agonist Drugs Price Forecast by Type (2024-2029) & (USD/MT)
Table 119. Global Opioids Agonist Drugs Sales (K MT) Forecast by Application (2024-2029)
Table 120. Global Opioids Agonist Drugs Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Opioids Agonist Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioids Agonist Drugs Market Size (M USD), 2018-2029
Figure 5. Global Opioids Agonist Drugs Market Size (M USD) (2018-2029)
Figure 6. Global Opioids Agonist Drugs Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioids Agonist Drugs Market Size by Country (M USD)
Figure 11. Opioids Agonist Drugs Sales Share by Manufacturers in 2022
Figure 12. Global Opioids Agonist Drugs Revenue Share by Manufacturers in 2022
Figure 13. Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Opioids Agonist Drugs Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioids Agonist Drugs Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioids Agonist Drugs Market Share by Type
Figure 18. Sales Market Share of Opioids Agonist Drugs by Type (2018-2023)
Figure 19. Sales Market Share of Opioids Agonist Drugs by Type in 2022
Figure 20. Market Size Share of Opioids Agonist Drugs by Type (2018-2023)
Figure 21. Market Size Market Share of Opioids Agonist Drugs by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioids Agonist Drugs Market Share by Application
Figure 24. Global Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 25. Global Opioids Agonist Drugs Sales Market Share by Application in 2022
Figure 26. Global Opioids Agonist Drugs Market Share by Application (2018-2023)
Figure 27. Global Opioids Agonist Drugs Market Share by Application in 2022
Figure 28. Global Opioids Agonist Drugs Sales Growth Rate by Application (2018-2023)
Figure 29. Global Opioids Agonist Drugs Sales Market Share by Region (2018-2023)
Figure 30. North America Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 32. U.S. Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Opioids Agonist Drugs Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Opioids Agonist Drugs Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 37. Germany Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Opioids Agonist Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Opioids Agonist Drugs Sales Market Share by Region in 2022
Figure 44. China Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Opioids Agonist Drugs Sales and Growth Rate (K MT)
Figure 50. South America Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 51. Brazil Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Opioids Agonist Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Opioids Agonist Drugs Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Opioids Agonist Drugs Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Opioids Agonist Drugs Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Opioids Agonist Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Opioids Agonist Drugs Market Share Forecast by Type (2024-2029)
Figure 65. Global Opioids Agonist Drugs Sales Forecast by Application (2024-2029)
Figure 66. Global Opioids Agonist Drugs Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of Opioids Agonist Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioids Agonist Drugs Market Size (M USD), 2018-2029
Figure 5. Global Opioids Agonist Drugs Market Size (M USD) (2018-2029)
Figure 6. Global Opioids Agonist Drugs Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioids Agonist Drugs Market Size by Country (M USD)
Figure 11. Opioids Agonist Drugs Sales Share by Manufacturers in 2022
Figure 12. Global Opioids Agonist Drugs Revenue Share by Manufacturers in 2022
Figure 13. Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Opioids Agonist Drugs Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioids Agonist Drugs Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioids Agonist Drugs Market Share by Type
Figure 18. Sales Market Share of Opioids Agonist Drugs by Type (2018-2023)
Figure 19. Sales Market Share of Opioids Agonist Drugs by Type in 2022
Figure 20. Market Size Share of Opioids Agonist Drugs by Type (2018-2023)
Figure 21. Market Size Market Share of Opioids Agonist Drugs by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioids Agonist Drugs Market Share by Application
Figure 24. Global Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 25. Global Opioids Agonist Drugs Sales Market Share by Application in 2022
Figure 26. Global Opioids Agonist Drugs Market Share by Application (2018-2023)
Figure 27. Global Opioids Agonist Drugs Market Share by Application in 2022
Figure 28. Global Opioids Agonist Drugs Sales Growth Rate by Application (2018-2023)
Figure 29. Global Opioids Agonist Drugs Sales Market Share by Region (2018-2023)
Figure 30. North America Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 32. U.S. Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Opioids Agonist Drugs Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Opioids Agonist Drugs Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 37. Germany Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Opioids Agonist Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Opioids Agonist Drugs Sales Market Share by Region in 2022
Figure 44. China Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Opioids Agonist Drugs Sales and Growth Rate (K MT)
Figure 50. South America Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 51. Brazil Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Opioids Agonist Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Opioids Agonist Drugs Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Opioids Agonist Drugs Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Opioids Agonist Drugs Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Opioids Agonist Drugs Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Opioids Agonist Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Opioids Agonist Drugs Market Share Forecast by Type (2024-2029)
Figure 65. Global Opioids Agonist Drugs Sales Forecast by Application (2024-2029)
Figure 66. Global Opioids Agonist Drugs Market Share Forecast by Application (2024-2029)
